Fujifilm
bd_51157bf200945e37 · schema v1 · pii pii-v1
Full breach record for Fujifilm →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Sarcoma on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Fujifilm has actively promoted the research and development of liposome formulations by harnessing its advanced nano-dispersion technology, analysis technology, and process technology cultivated and evolved through its wide range of product development. In 2017, the company began a U.S. Phase I clinical trial of FF-10832, a liposome-based agent that encapsulates the approved anti-cancer agent gemcitabine *** . In the preclinical mice studies on FF-10850 and FF-10832 *4 Fujifilm has observed the extension of the survival period as a result of immune checkpoint inhibitor *5 combination therapy. In addition, Fujifilm has been promoting the application of liposome for use with next-generation drugs such as nucleic acid drugs and gene therapy drugs. Looking towards future growth, in order to ensure a stable supply of high-quality liposome formulations, Fujifilm is developing a manufacturing facility for producing investigational and commercial drugs through its subsidiary, FUJIFILM Toyama.Geo: Singapore - Leak size: NO DATA 1 pdf - Contains: NO DATA 1 pdf
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Apr 5, 2025
- Raw hash
- 87942794bf39a1e1de881f868ab0d72259945626116e3e0698e03852807ece8e
Reporting entity
- Name
- sarcoma
Victim entity
- Name
- Fujifilmnorm: fujifilm
- Domain
- fujifilm.com
- Industry
- Technology
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· sarcoma
- Threat actor
- SarcomaExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.